Lindahl advised Prostatype Genomics on the deal.Prostatype Genomics AB (publ), a company listed on Nasdaq First North Growth Market, develops and markets a prognostic gene test…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
